Zobrazeno 1 - 10
of 343
pro vyhledávání: '"Stefano, Molica"'
Publikováno v:
Case Reports in Hematology, Vol 2024 (2024)
The coexistence of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) in the same patient is exceedingly rare, with only a few cases reported in the literature. Here, we report a patient with CML who, having achieved a major molecu
Externí odkaz:
https://doaj.org/article/3cd324b96ba24b538be69dd75063662f
Autor:
Simone Oerlemans, Fabio Efficace, Omar Shamieh, Fabio Cardoso Borges, Corine De Jong, Dong Dong, Jens Lehmann, Sandra Malak, Duska Petranovic, Christian Scholz, Giovanni Caocci, Stefano Molica, Laimonas Griskevicius, Eva Nagele, Anne Bredart, Elisabete Carvalho, Aliki Xochelli, Joost Agelink van Rentergem, Waleed Alrjoob, Anja Mueller, Ana Carolina Freitas, Kim Cocks, Carien Creutzberg, Charalampia Kyriakou, Lonneke Van de Poll-Franse
Publikováno v:
HemaSphere, Vol 7, p e52692b6 (2023)
Externí odkaz:
https://doaj.org/article/c3f36cb5e4044209bc2ca8c4f6ac182c
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia. B-cell depleting therapies have
Externí odkaz:
https://doaj.org/article/32fbe03366384be698cd924edc236c5a
Autor:
Andrea Visentin, Francesca Romana Mauro, Gioachino Catania, Alberto Fresa, Candida Vitale, Alessandro Sanna, Veronica Mattiello, Francesca Cibien, Paolo Sportoletti, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Roberta Murru, Alessandro Gozzetti, Stefano Molica, Monia Marchetti, Stefano Pravato, Francesco Angotzi, Alessandro Cellini, Lydia Scarfò, Gianluigi Reda, Marta Coscia, Luca Laurenti, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
One of the main issues in the treatment of patients with chronic lymphocytic leukemia (CLL) deals with the choice between continuous or fixed-duration therapy. Continuous ibrutinib (IB), the first-in-class BTK inhibitor, and obinutuzumab-chlorambucil
Externí odkaz:
https://doaj.org/article/26e89ef70eee4bd594a63aa05621a090
Autor:
Luca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, Stefano Molica, Patrizio Pasqualetti, Lydia Scarfò, Paolo Ghia
Publikováno v:
HemaSphere, Vol 6, Iss 9, p e771 (2022)
Several treatment options are available for chronic lymphocytic leukemia (CLL) and, for this reason, treatment choice can result challenging after introducing oral targeted agents. This study aims at comparing patients’ and hematologists’ prefere
Externí odkaz:
https://doaj.org/article/4d8b4e70d2b841e9b60e0783076e18e8
Autor:
Antonio Cuneo, Anthony R. Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N. Allan, John M. Pagel, Danielle M. Brander, Brian T. Hill, Allison Winter, Nicole Lamanna, Constantine S. Tam, Ryan Jacobs, Frederick Lansigan, Paul M. Barr, Mazyar Shadman, Alan P. Skarbnik, Jeffrey J. Pu, Alison R. Sehgal, Stephen J. Schuster, Nirav N. Shah, Chaitra S. Ujjani, Lindsey Roeker, Ester Maria Orlandi, Atto Billio, Livio Trentin, Martin Spacek, Monia Marchetti, Alessandra Tedeschi, Fiorella Ilariucci, Gianluca Gaidano, Michael Doubek, Lucia Farina, Stefano Molica, Francesco Di Raimondo, Marta Coscia, Francesca Romana Mauro, Javier de la Serna, Angeles Medina Perez, Isacco Ferrarini, Giuseppe Cimino, Maurizio Cavallari, Rosalba Cucci, Marco Vignetti, Robin Foà, Paolo Ghia, the GIMEMA, European Research Initiative (ERIC) on CLL, US study group
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8468-8479 (2020)
Abstract Limited information is available on the efficacy of front‐line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real‐world patie
Externí odkaz:
https://doaj.org/article/51d4f3af2edb4e18930e0b7ba14d8eff
Autor:
Stefano Molica, Paolo Sportoletti, Nicola Di Renzo, Pellegrino Musto, Fabrizio Pane, Francesco Di Raimondo
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 13, Iss 1 (2021)
With more than 3 million proven infections and 100.000 associated deaths in Italy, the COVID-19 pandemic poses extraordinary challenges to health-care professionals and especially to those caring for patients with haematologic malignancies (1-2). Giv
Externí odkaz:
https://doaj.org/article/8b865993864446f6bb19eb47e1dd631c
Autor:
Maria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, Paola Mariglia, Maria Stefania De Propris, Luca Vincenzo Cappelli, Livio Trentin, Gianluigi Reda, Antonio Cuneo, Stefano Molica, Alfonso Piciocchi, Valentina Arena, Francesca Romana Mauro, Anna Guarini, Robin Foà
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Ibrutinib may revert the T-helper (Th)2 polarization observed in chronic lymphocytic leukemia (CLL) by targeting the IL-2-inducible kinase, that shows a significant homology with the Bruton tyrosine kinase. In the front-line GIMEMA LLC1114 trial (ibr
Externí odkaz:
https://doaj.org/article/cd628b4fa6a448cf8cad11aced4c9099
Autor:
Stefano Molica, Diana Giannarelli
Publikováno v:
Leukemia & Lymphoma. 64:889-892
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e67e9d47b487397cba8dd4ad84e2e5d4
https://doi.org/10.1080/10428194.2023.2181656
https://doi.org/10.1080/10428194.2023.2181656
Publikováno v:
European Journal of Haematology. 110:774-777
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04fb521b00b23bff2bccc3be6c6243f3
https://doi.org/10.1111/ejh.13943
https://doi.org/10.1111/ejh.13943